Variable effect of growth hormone on growth and final adult height in Scottish patients with Turner's syndrome

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 2, 1997, Pages 160-164

  Chu, C E ^a,e   Paterson, W F ^a   Kelnar, C J H ^b   Smail, P J ^c   Greene, S A ^d   Donaldson, M D C ^a  

^a Department of Clinical Genetics ^*  (United Kingdom)

^b Section of Child Life and Health   (United Kingdom)

^c NHS GRAMPIAN   (United Kingdom)

^d NINEWELLS HOSPITAL   (United Kingdom)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

final height; recombinant growth hormone; ring X; Turner's syndrome

Indexed keywords

ESTROGEN; HUMAN GROWTH HORMONE; OXANDROLONE; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ARTICLE; BODY GROWTH; CHILD; DRUG EFFECT; GROWTH HORMONE DEFICIENCY; HEIGHT; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TURNER SYNDROME; UNITED KINGDOM;

EID: 0031034601     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb08858.x     Document Type: Article

References (14)

1. Rongen-Westerlaken C, Wit JM. Growth hormone therapy in Turner syndrome: the Dutch experience. In: Ranke MB, Rosenfeld RG, editors. Turner syndrome: growth promoting therapies. Amsterdam: Elsevier Science, 1991: 225-30
2. Rosenfeld RG, and the Genetech National Cooperative Study Group. Growth hormone therapy in Turner's syndrome: an update on final height. Acta Paediatr Suppl 1992; 383: 3-8
3. Massa G, Otten BJ, De Muink Keizer-Schrama SMPF, Jansen M, Vulsma T, Oostdijk W, et al. Treatment with two growth hormone regimes in girls with Turner syndrome: final height results. Horm Res 1995; 43; 144-6, 225-30
4. Van de Broek J, Massa GG, Attanasio A, Matranga A, Chaussin J-L, Price D, et al. Final height after long-term growth hormone treatment in Turner syndrome. J Pediatr 1995; 127: 729-35
5. Ranke MB, Guilbraud O. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. Acta Paediatr Scand Suppl 1993; 391: 82-8
6. Tanner JM, Whitehouse RH, Takaishi M. Standards for height, weight, height velocity and weight velocity: British children, 1965. Arch Dis Child 1966; 41: 454-71, 613-25
7. Ranke MB, Stubbe P, Majewski F, Bierich JR. Spontaneous growth in Turner's syndrome. Acta Paediatr Scand Suppl 1988; 343: 22-30
8. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child 1985; 60: 932-5
9. Chu CE, Donaldson MDC, Kelnar CJH, Smail PJ, Greene SA, Paterson WF, et al. Possible role of imprinting in the Turner phenotype. J Med Genet 1994; 31: 840-2
10. Rochiccioli P, David M, Malpeuch G, Colle M, Limal JM, Battin J, et al. Study of final height in Turner's syndrome: ethnic and genetic influences. Acta Paediatr 1994; 83: 305-8
11. Price DA, Albertsson-Wikland K. Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kahi Pharmacia International Growth Study. Acta Paediatr Suppl 1993; 391: 69-74
12. Takano K, Shizume K, Hibi I, Ogawa M, Okado Y, Suwa S, et al. Long-term effects of growth hormone treatment on height in Turner syndrome: results of a 6-year multicentre study in Japan. Horm Res 1995; 43: 141-3
13. Rochiccioli P, Battin J, Bertrand AM, Bost M, Cabrol S, Le Bouc Y, et al. Final height in Turner syndrome patients treated with growth hormone. Horm Res 1995; 44: 172-6
14. Heinrichs C, De Schepper J, Thomas M, Massa G, Craen M, Lalvaux P, et al. Final height in 46 girls with Turner syndrome treated with growth hormone in Belgium: evaluation of height recovery and predictive factors. In: Albertsson-Wikland K, Ranke MB, editors, Turner syndrome in a life-span perspective. Amsterdam: Elsevier Science, 1995: 137-47